4.7 Article

Heterogeneity in chronic myeloid leukaemia dynamics during imatinib treatment: role of immune responses

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemical Research Methods

Dynamics and potential impact of the immune response to chronic myelogenous leukemia

Peter S. Kim et al.

PLOS COMPUTATIONAL BIOLOGY (2008)

Article Multidisciplinary Sciences

Effect of Cellular Quiescence on the Success of Targeted CML Therapy

Natalia L. Komarova et al.

PLOS ONE (2007)

Article Hematology

Optimizing therapy of chronic myeloid leukemia

Michael W. N. Deininger

EXPERIMENTAL HEMATOLOGY (2007)

Article Medicine, General & Internal

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

Moshe Talpaz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Multidisciplinary Sciences

Dynamics of chronic myeloid leukaemia

F Michor et al.

NATURE (2005)

Article Multidisciplinary Sciences

Overriding imatinib resistance with a novel ABL kinase inhibitor

NP Shah et al.

SCIENCE (2004)

Review Hematology

The biology of CML blast crisis

B Calabretta et al.

Article Hematology

Mechanisms and implications of imatinib resistance mutations in BCR-ABL

V Nardi et al.

CURRENT OPINION IN HEMATOLOGY (2004)

Review Pharmacology & Pharmacy

Specific targeted therapy of chronic myelogenous leukemia with imatinib

MWN Deininger et al.

PHARMACOLOGICAL REVIEWS (2003)

Article Multidisciplinary Sciences

Boosting immunity by antiviral drug therapy: A simple relationship among timing, efficacy, and success

NL Komarova et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)